Айламазян Э. К.
Антенатальная диагностика и коррекция нарушений развития плода// Российский
вестник перинаталогии и педиатрии. 1999. №3. с. 6-11.
Гинзбург Б. Г.
Динамика частоты синдрома Дауна в разных регионах. //Российский вестник
перинаталогии и педиатрии. 2000; №3: с.58.
Wald N. J, Cuckle H. S, Densem J. W. et al. Maternal
serum screening for Downs syndrome in early pregnancy // BMJ. 1988; 297: 883-7.
Пренатальная
диагностика в акушерстве: современное состояние, методы, перспективы.
Методическое пособие под ред. Э.К. Айламазяна. СПб.: Изд-во Н-Л. 2002.
Merkatz I. R. , Nitowsky H. M. , Macri J. N., Johnson
W. E. An Association between low maternal serum α-fetoprotein (AFP) and fetal chromosomal
abnormalities.//Am. J. Obstet. Gynecol.1984; 148: 886-94.
Bogart H. M., Pandian M. R., Jones O. W. Abnormal
maternal serum chorionic gonadotropin levels in pregnancies with fetal
chromosome abnormalities // Prenat. Diagn. 1987; 7: 623-30.
Wald NJ, Watt HC, Hackshaw AK. Integrated screening
for downs syndrome based on tests performed during the first and second
trimesters. //The New Engl. J. Med. 1999. 341/7: 461-467.
Krantz D.A., Larsen J.W., Buchanan P.D., Macri J.N.
First-trimester Down syndrome screening: Free β-human chorionic gonadotropin and
pregnancy-associated plasma protein A // Am. J. Obstet. Gynecol. 1996; 174:
612-6.
Miller S. M., Isabel J. M. Prenatal screening tests
facilitate risk assessment // MlO. 2002. 2: 8-19.
Розен В. Б.
Основы эндокринологии. М.: Изд-во МГУ, 1994. с. 89.
Lapthorn A. J., Hariris D. C., Littlejohn A. et al.
Crystal structure of human chorionic gonadotropin. // Nature. 1994. 369.9:
455-61.
McDonald N. Q., Lapatto R., Murray-Rust J. et al. New
protein fold revealed by 2.3 A resolution crystal structure of nerve growth
factor // Nature. 1991. 354: 411-14.
Schlunegger M. P., Grutter M. G. An unusual feature
reveal to end by the crystal structure at 2.2 A resolution of human
transforming growth factor-β2. //
Nature. 1992. 358: 430-34.
Oefner C., Darey A., Winkler F. K. et al. Crystal
structure of human platelet-derived growth factor B. // EMBO J. 1992. 11:
3921-26.
Elliot M., Kardana A., Lustbader J. W., Cole L. A.
Carbohydrate and peptide structure of the α- and β-subunits
of human chorionic gonadotropin from normal and aberrant pregnancy and
choriocarcinoma.// Endocrine. 1988. 5: 2221-33.
Boorstein W. R., Vamvakopoulos N. C., Fiddes J. C.
Human chorionic gonadotropin β-subunit
is encoded by at least eight genes arranged in tandem, inverted pairs. //
Nature. 1982. 300: 419-22.
Policastro P., Ovitt C. E., Hoshina M. et al. The β-subunit of human
chorionic gonadotropin is encoded by multiple genes. // JBC. 1983. 258:
11492-99.
Boothby M., Kukowska J., Boime I. Imbalanced of human
choriogonadotropin alpha, beta subunits reflects the steady state levels of the
corresponding mRNAs. // JBC. 1983. 258: 9250-53.
Blithe D. L., Iles R. K. The role of glycosylation in
regulating the glycoprotein hormone free alpha-subunit and free beta-subunit
combination in the extraembryonic coelomic fluid of early pregnancy. //
Endocrinology. 1995. 136: 903-910.
Cole L. A., Kardana A., Park S-Y., Braustein G. D. The
deactivation of hCG by nicking and dissociation.// J. of clin. End. and Metab.
1993; 76(3): 704-10.
Spencer K., Macri J. N., Carpenter P. et al. Stability
of intact chorionic gonaotropin in serum. Liquid whole blood and dried
whole-blood filter-paper. // Clin. Chem. 1993. 39/6: 1064-68.
Cole L. A, Kardana A., Andrade-Gordon P. et al. The
heterogeneity of hCG: III. The occurence, biological and immunological
activities of nicked hCG. // Endocrinology. 1991. 129: 1559-67.
Cole L. A. Immunoassay of human chorionic
gonadotropin, its free subunits, and metabolites. // Clin Chem. 1997; 43(12):
2233-43.
Pittaway D. E , Reiosh R. L. , Wentz A. C. Doubling
times of human chorionic ginadotropin increase in early viable intrauterine
pregnancies. // Am. J. Obstet. Gynecol. 1985. 152: 299-302.
Рекомендуем скачать другие рефераты по теме: курсовые, реферат на тему ресурсы.